U.S. Arrests Former Green Beret, Son, in Connection with Carlos Ghosn Escape From Japan
U.S. arrests former Green Beret and son in connection with former Nissan Motor Chairman Carlos Ghosn's escape from Japan to avoid a corruption trial.
Luckin Coffee Shares Tumble After Nasdaq Lifts Trading Suspension
Shares of Luckin Coffee resumed trading following a six-week hiatus, tumbling early after the Nasdaq Stock Market told the Chinese coffee chain that it could be delisted.
Target Gains Strength During Coronavirus
Target said sales surged in the most recent quarter, driven initially by online shoppers who stockpiled food and other essentials to brace for coronavirus lockdowns and more recently by rising demand for items like electronics and apparel as states have begun to lift stay-at-home orders.
Ares Targets EUR9 Billion for Latest European Debt Fund
The U.S. private-equity firm is pitching a European credit fund that would surpass the EUR6.5 billion it raised for the strategy less than two years ago, people familiar with the situation said.
Harley Plans for Fewer Models, Simpler Factories After Coronavirus Shutdown
Harley-Davidson is reopening its factories this week at lower production rates and sending dealers a narrower range of motorcycles, steering away from more expansive plans to stop a yearslong sales slide.
Inside Facebook and Private Equity's $8.8 Billion Bet on India's Richest Man
Facebook and a trio of U.S. private-equity firms have in the past month poured billions of dollars into an upstart mobile operator controlled by India's richest man.
Tech Chiefs Press Cloud Suppliers for Consistency on Security Data
Each cloud company offers its own process on cybersecurity and governance, creating added work for customers.
Rolls-Royce to Cut 17% of Workforce
Rolls-Royce will cut 9,000 jobs from its global workforce as it looks to weather what it expects to be years-long impact on air travel demand triggered by the novel coronavirus.
Lenovo Expects PC Sales Growth to Resume in June Quarter, CEO Says
Sales recovery will be capped by component availability, with CEO Yang Yuanqing noting the company still faces some shortages, as the pandemic has crippled suppliers' production and transportation.
Generic Drugmaker Gets Contract to Make Covid-19 Medicines in U.S.
A new generic drugmaker said it was awarded $354 million in federal funding to make prescription drugs and their raw ingredients in the U.S., including some medicines used to treat patients infected with Covid-19.
